IRIS
CATENA, Cristiana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.197
AS - Asia 7.115
EU - Europa 6.109
SA - Sud America 1.473
AF - Africa 125
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 10
Totale 33.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.980
SG - Singapore 3.427
UA - Ucraina 1.835
CN - Cina 1.628
BR - Brasile 1.247
DE - Germania 1.064
IT - Italia 1.040
HK - Hong Kong 894
FI - Finlandia 719
RU - Federazione Russa 468
VN - Vietnam 372
IE - Irlanda 310
SE - Svezia 207
TR - Turchia 200
GB - Regno Unito 138
CA - Canada 136
KR - Corea 135
IN - India 118
AR - Argentina 93
BD - Bangladesh 62
FR - Francia 57
AT - Austria 48
MX - Messico 47
ZA - Sudafrica 45
BE - Belgio 39
PL - Polonia 39
IQ - Iraq 37
NL - Olanda 35
JP - Giappone 34
EC - Ecuador 31
ID - Indonesia 30
ES - Italia 27
CO - Colombia 26
CZ - Repubblica Ceca 26
PK - Pakistan 24
EU - Europa 21
VE - Venezuela 19
MA - Marocco 17
IR - Iran 16
UZ - Uzbekistan 16
CL - Cile 14
EG - Egitto 13
PE - Perù 13
PY - Paraguay 13
IL - Israele 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
SA - Arabia Saudita 10
UY - Uruguay 10
AU - Australia 9
AZ - Azerbaigian 9
KE - Kenya 9
TN - Tunisia 9
CR - Costa Rica 8
KZ - Kazakistan 8
LB - Libano 8
TG - Togo 8
LT - Lituania 6
RS - Serbia 6
TW - Taiwan 6
AM - Armenia 5
BO - Bolivia 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
MY - Malesia 5
PS - Palestinian Territory 5
RO - Romania 5
XK - ???statistics.table.value.countryCode.XK??? 5
EE - Estonia 4
KH - Cambogia 4
NP - Nepal 4
PA - Panama 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AL - Albania 3
BW - Botswana 3
DK - Danimarca 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AO - Angola 2
BT - Bhutan 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
ME - Montenegro 2
MU - Mauritius 2
NI - Nicaragua 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
Totale 33.023
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.091
Fairfield 1.829
Ann Arbor 1.474
Singapore 1.349
Jacksonville 1.305
Ashburn 1.281
Houston 1.119
Chandler 975
Hong Kong 892
Beijing 819
Dearborn 788
Wilmington 783
Seattle 723
Cambridge 648
Boardman 431
Princeton 336
Dublin 308
Munich 270
Los Angeles 203
Udine 182
Buffalo 171
Izmir 161
Hefei 150
Dallas 134
San Diego 128
Helsinki 124
Seoul 124
Ho Chi Minh City 104
Redondo Beach 96
São Paulo 94
New York 85
Milan 80
Ottawa 79
Des Moines 74
Hanoi 74
Ogden 71
Norwalk 65
Dong Ket 53
Nanjing 51
Kunming 49
Redmond 47
Rome 45
San Mateo 45
Rio de Janeiro 40
Guangzhou 39
Santa Clara 39
Warsaw 38
Mumbai 37
Nuremberg 33
Brooklyn 30
Brussels 30
Belo Horizonte 29
Tokyo 29
Johannesburg 27
Phoenix 27
Brasília 26
Vienna 26
Grafing 25
Falls Church 24
Shanghai 24
Atlanta 23
Boston 23
Stockholm 23
Brno 22
Frankfurt am Main 22
Turku 22
London 21
San Francisco 21
Trieste 21
Chicago 20
Council Bluffs 20
Düsseldorf 20
Denver 19
Jinan 19
Montreal 19
Washington 19
Chennai 17
Goiânia 17
Mexico City 17
Orem 17
Ankara 16
Porto Alegre 16
Amsterdam 14
Fortaleza 14
Baghdad 13
Fuzhou 13
Guayaquil 13
Mcallen 13
Poplar 13
Tashkent 13
Curitiba 12
Haiphong 12
New Delhi 12
Toronto 12
Xi'an 12
Changsha 11
Codroipo 11
Da Nang 11
Indiana 11
Lappeenranta 11
Totale 21.088
Salva come PNG Salva come JPEG
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 257
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 252
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 226
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 213
Aldosterone and the heart: from basic research to clinical evidence 185
Abnormalities of insulin receptors in spontaneously hypertensive rats 184
Aldosterone and Left Ventricular Remodeling 178
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 174
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 166
Aldosterone, Organ Damage, and Dietary Salt 164
Aldosterone and the heart: still an unresolved issue? 163
Abnormalities of glucose metabolism in patients with early renal failure 160
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 160
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 157
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 156
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 155
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 155
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 155
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 153
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 152
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 150
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 148
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 148
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 147
The emergent cardiovascular risk factors and organ damage in arterial hypertension 146
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 145
Diabetes, diabetic complications, and blood pressure targets 144
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 143
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 143
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 143
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 142
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 142
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 142
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 142
Prohypertensive effect of insulin: possible role of the sympathetic system 141
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 140
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 140
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 138
Benzodiazepines: an old class of new antihypertensive drugs? 138
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 138
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 138
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 138
Treatment of primary aldosteronism and organ protection 138
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 136
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 136
Salt, hypertension, and cardiovascular disease 134
Cardiovascular outcomes in patients with primary aldosteronism after treatment 134
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 133
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 133
Renal function in primary aldosteronism 132
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 132
Spontaneous restoration of sinus rhythm after cardiac surgery 132
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 131
Kidney in primary aldosteronism: a key determinant of treatment outcome 131
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 131
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 130
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 130
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 130
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 129
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 129
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 129
The SPARTACUS Trial: Controversies and Unresolved Issues 128
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 127
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 127
Benign familial macrocytosis 126
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 125
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 125
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 125
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 124
Potassium-sparing diuretics in hypertension 124
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 124
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 124
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 124
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 123
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 122
Abnormalities of carbohydrate metabolism and cardiovascular disease in patients with early renal failure 121
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 121
Glucose metabolism in early renal failure 121
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 121
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 121
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 119
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 117
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 116
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 116
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 116
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 116
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 116
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 115
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 115
Hypertension and abnormalities of carbohydrate metabolism: possible role of sympathetic nervous system 114
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 114
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial 114
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 114
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 113
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 113
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 113
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 113
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 113
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension 113
Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes 113
Totale 13.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.515 0 0 0 0 0 497 198 431 642 131 432 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20255.930 141 420 174 184 116 320 396 383 640 431 1.073 1.652
2025/20265.651 783 1.138 906 1.015 1.668 141 0 0 0 0 0 0
Totale 33.931